In March 2020, a class-action lawsuit was filed against Purell for allegedly deceptively marketing that Purell hand sanitizer “kills 99.99% of illness causing germs,” is “2X” more powerful than competitors’ products, and helps prevent infection and diseases – including colds, influenza, norovirus, ebola, MRSA, and VRE – when, according to the complaint, there is no adequate scientific evidence to support such claims. Plaintiffs also claim that the company does not have adequate support for the statistics in the marketing materials. (Miller et al v. Gojo Industries, Inc. d/b/a Purell, Case No. 20-cv-562, N.D. Ohio)
For more of TINA.org’s coverage of the marketing of hand sanitizers, click here.
In March 2020, a class-action lawsuit was filed against Gojo Industries for allegedly misleadingly advertising that Purell Advanced Hand Sanitizer gels and foams “Kill[] 99.99% of Illness Causing Germs” and…
In January 2020, a class-action lawsuit was filed against Gojo Industries for allegedly deceptively marketing that Purell hand sanitizers will prevent and reduce the flu and other viruses when, according…
In February 2020, a class-action lawsuit was filed against Purell for allegedly falsely advertising that Purell Advanced Hand Sanitizer products “kill[] more than 99.99% of most common germs” and prevent…
In January 2020, a class-action lawsuit was filed against Purell for allegedly falsely advertising Purell Advanced Hand Sanitizers. Plaintiffs claim that the company misleadingly advertises that the hand sanitizers “[k]ill[]…
In February 2020, a class-action lawsuit was filed against Gojo Industries for allegedly misleadingly marketing that Purell Advanced Hand Sanitizer products “Kill[] 99.99% of Illness Causing Germs” when, according to…
The bottom line: Only FDA-approved drugs can be marketed to prevent disease.